Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Shandong Xinhua Pharmaceutical Co Ltd
F:XIN
Shandong Xinhua Pharmaceutical Co Ltd
F:XIN
Price:
0.61
EUR
Market Cap:
€1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shandong Xinhua Pharmaceutical Co Ltd
F:XIN
|
CN |
Wall St Price Targets
XIN Price Forecast
Based on 3 analysts
Based on 3 analysts
-9% Downside
from
€0.61
today
Shandong Xinhua Pharmaceutical Co Ltd (XIN)’s 12-month stock price forecast through September 2027 has a consensus target of €0.55, implying 9% downside. The forecast is based on price targets from 3 Wall Street analysts.
XIN Analyst Rating
No ratings yet
No ratings yet
Shandong Xinhua Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XIN's stock price target?
Price Target
0.55
EUR
0.55
EUR
According to Wall Street analysts, the average 1-year price target for XIN is 0.55 EUR with a low forecast of 0.55 EUR and a high forecast of 0.57 EUR.
What is the Revenue forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
2%
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
25%
25%
Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 2 years is 25%.
What is the Pre-Tax Income forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
43%
43%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 2 years is 43%.
What is the Net Income forecast for Shandong Xinhua Pharmaceutical Co Ltd?
Projected CAGR
47%
47%
Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 2 years is 47%.